A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

Human tuberculosis remains a significant cause of mortality and morbidity throughout the world. The global economic impact of bovine TB is considerable. An effective vaccine would be the most cost-effective way to control both epidemics, particularly in emerging economies. TB vaccine research would...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Pepponi, I, Khatri, B, Tanner, R, Villarreal-Ramos, B, Vordermeier, M, McShane, H
Format:	Journal article
Veröffentlicht:	Elsevier 2017

Ähnliche Einträge

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
von: Brennan, M, et al.
Veröffentlicht: (2017)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
von: Tanner, R, et al.
Veröffentlicht: (2021)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
von: Tanner, R, et al.
Veröffentlicht: (2021)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
von: Rachel Tanner, et al.
Veröffentlicht: (2021-09-01)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
von: Painter, H, et al.
Veröffentlicht: (2024)

Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates
von: Tanner, R
Veröffentlicht: (2015)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
von: Tanner, R, et al.
Veröffentlicht: (2020)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
von: Painter, H, et al.
Veröffentlicht: (2024)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
von: Hannah Painter, et al.
Veröffentlicht: (2024-02-01)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis
von: McShane, H, et al.
Veröffentlicht: (2016)

The humoral immune response to BCG vaccination
von: Tanner, R, et al.
Veröffentlicht: (2019)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
von: Mcshane, H, et al.
Veröffentlicht: (2017)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
von: Tanner, R, et al.
Veröffentlicht: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
von: Marsay, L, et al.
Veröffentlicht: (2013)

The Humoral Immune Response to BCG Vaccination
von: Rachel Tanner, et al.
Veröffentlicht: (2019-06-01)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
von: Tanner, R, et al.
Veröffentlicht: (2017)

Towards new TB vaccines
von: Brazier, B, et al.
Veröffentlicht: (2020)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
von: Marsay, L, et al.
Veröffentlicht: (2013)

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells
von: Tanner, R, et al.
Veröffentlicht: (2019)

Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen
von: Biffar, L, et al.
Veröffentlicht: (2019)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
von: Dean, G, et al.
Veröffentlicht: (2014)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
von: Fletcher, H, et al.
Veröffentlicht: (2013)

TB vaccines in clinical development
von: Ginsberg, AM, et al.
Veröffentlicht: (2016)

A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity
von: Emil Joseph Vergara, et al.
Veröffentlicht: (2024-07-01)

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection
von: Hyejon Lee, et al.
Veröffentlicht: (2019-04-01)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
von: Painter, H, et al.
Veröffentlicht: (2020)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
von: Vordermeier, H, et al.
Veröffentlicht: (2009)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
von: Hannah Painter, et al.
Veröffentlicht: (2020-02-01)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
von: Villarreal-Ramos, B, et al.
Veröffentlicht: (2017)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
von: O'Shea, M, et al.
Veröffentlicht: (2018)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
von: Dean, G, et al.
Veröffentlicht: (2014)

A review of clinical models for the evaluation of human TB vaccines.
von: O'Shea, M, et al.
Veröffentlicht: (2016)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
von: Vordermeier, H, et al.
Veröffentlicht: (2011)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
von: Tanner, R, et al.
Veröffentlicht: (2021)

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis, (vol 77, pg 3371, 2009)
von: Vordermeier, H, et al.
Veröffentlicht: (2011)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
von: Rachel Tanner, et al.
Veröffentlicht: (2021-01-01)

Immunological mechanisms of tuberculosis susceptibility in TB-infected individuals with type 2 diabetes mellitus: insights from mycobacterial growth inhibition assay and cytokine analysis
von: Bindu Dasan, et al.
Veröffentlicht: (2025-01-01)

Progress and challenges in TB vaccine development
von: Voss, G, et al.
Veröffentlicht: (2018)

Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection
von: O'Shea, M, et al.
Veröffentlicht: (2018)

Need for more TB vaccine field sites.
von: Mcshane, H
Veröffentlicht: (2009)